Form 4: Marimed Director Edward J. Gildea Converts Restricted Stock Units into 75,000 Common Shares

Marimed Inc. Director Edward J. Gildea converted 75,000 Restricted Stock Units into common stock, increasing his direct beneficial ownership to 657,823 shares.

Summary

• Edward J. Gildea, a Director of Marimed Inc. (MRMD), reported a change in his beneficial ownership of the company's securities.
• On June 6, 2025, Mr. Gildea acquired 75,000 shares of Marimed Inc. common stock through the conversion of Restricted Stock Units (RSUs).
• The acquisition price for these shares was $0, indicating a non-cash conversion of previously granted equity awards.
• The 75,000 RSUs were granted on June 6, 2024, and vested in full on June 6, 2025, in accordance with an agreement between Marimed Inc. and Mr. Gildea.
• Following this transaction, Edward J. Gildea directly beneficially owns a total of 657,823 shares of Marimed Inc. common stock.

Sentiment

Score: 6

Explanation: The conversion of Restricted Stock Units into common stock by a director is a routine transaction that increases insider ownership, which can be viewed positively as it aligns management interests with shareholders. It is not a direct purchase or sale, so its immediate impact on sentiment is neutral to slightly positive.

Positives

• The conversion of Restricted Stock Units into common stock increases the direct beneficial ownership of a director, which can align management interests more closely with those of shareholders.

Future Outlook

This SEC Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

This filing is a routine insider transaction report specific to Marimed Inc. and does not provide broader industry context or trends.

Related Party Transactions

• The transaction involves the conversion of Restricted Stock Units (RSUs) granted by Marimed Inc. to its director, Edward J. Gildea, as part of his compensation, which is a standard related-party compensation arrangement.

Stakeholder Impact

• Shareholders: Increased alignment of director's interests with shareholder value due to higher direct stock ownership.

Key Dates

Recommendation

Keywords

Marimed Inc., MRMD, Form 4, Insider Transaction, Restricted Stock Units, RSU Conversion, Director Stock Ownership, Edward J. Gildea